University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor

Wen T. Shen, M.D.

Endocrine surgeon

Dr. Wen T. Shen is a surgeon specializing in procedures for thyroid, parathyroid and adrenal gland surgery. He treats patients primarily at UCSF Medical Center at Mount Zion and the UCSF Helen Diller Family Comprehensive Cancer Center. His research focuses on the molecular biology, genetics and treatment of thyroid cancer as well as the use of minimally invasive surgery. Shen also has an interest in medical history and has studied the development of hormonal therapies for benign and malignant conditions and the impact of the 1942 Coconut Grove Fire in Boston on the evolution of surface treatment for burns.

Shen graduated magna cum laude at Harvard College, where he earned a bachelor's degree in history and science. He earned a medical degree and completed a surgical residency and research fellowship in endocrine surgery at UCSF. He received the Esther Nusz Achievement Award from the UCSF Department of Surgery, Resident's Prize from the Pacific Coast Surgical Association, William Osler Medal from the American Association for the History of Medicine and Rothschild Prize from the Department of the History of Science at Harvard University. He is an assistant professor in residence in surgery at UCSF.

Clinics

Endocrine Surgical and Oncology Clinic
1600 Divisadero St., Third Floor
San Francisco, CA 94115
Phone: (415) 353–7687
Fax: (415) 353–7781

Hours: Monday to Friday, 9 a.m. – 5 p.m.

Conditions & Treatments

More about Wen T. Shen

Education

UCSF 1999

Residencies

UCSF Medical Center, Surgery 2007

Fellowships

UCSF, Endocrine Surgery 2005

Selected Research and Publications

  1. Scholten A, Cisco RM, Vriens MR, Cohen JK, Mitmaker EJ, Liu C, Tyrrell JB, Shen WT, Duh QY. Pheochromocytoma crisis is not a surgical emergency. J Clin Endocrinol Metab. 2013 Feb; 98(2):581-91.
  2. Tsinberg M, Duh QY, Cisco RM, Gosnell JE, Scholten A, Clark OH, Shen WT. Practice patterns and job satisfaction in fellowship-trained endocrine surgeons. Surgery. 2012 Dec; 152(6):953-6.
  3. Schreinemakers JM, Vriens MR, Munoz-Perez N, Guerrero MA, Suh I, Rinkes IH, Gosnell J, Shen WT, Clark OH, Duh QY. Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management. World J Surg Oncol. 2012; 10:192.
  4. Cisco RM, Shen WT, Gosnell JE. Extent of surgery for papillary thyroid cancer: preoperative imaging and role of prophylactic and therapeutic neck dissection. Curr Treat Options Oncol. 2012 Mar; 13(1):1-10.
  5. Mitmaker EJ, Griff NJ, Grogan RH, Sarkar R, Kebebew E, Duh QY, Clark OH, Shen WT. Modulation of matrix metalloproteinase activity in human thyroid cancer cell lines using demethylating agents and histone deacetylase inhibitors. Surgery. 2011 Apr; 149(4):504-11.
  6. Shen WT, Grogan R, Vriens M, Clark OH, Duh QY. One hundred two patients with pheochromocytoma treated at a single institution since the introduction of laparoscopic adrenalectomy. Arch Surg. 2010 Sep; 145(9):893-7.
  7. Suh I, Vriens MR, Guerrero MA, Griffin A, Shen WT, Duh QY, Clark OH, Kebebew E. Serum thyroglobulin is a poor diagnostic biomarker of malignancy in follicular and Hurthle-cell neoplasms of the thyroid. Am J Surg. 2010 Jul; 200(1):41-6.
  8. Grogan RH, Mitmaker E, Vriens MR, Harari A, Gosnell JE, Shen WT, Clark OH, Duh QY. Adrenal incidentaloma: does an adequate workup rule out surprises? Surgery. 2010 Aug; 148(2):392-7.
  9. Shen WT, Ogawa L, Ruan D, Suh I, Duh QY, Clark OH. Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery. 2010 Aug; 148(2):398-403.
  10. Suh I, Weng J, Fernandez-Ranvier G, Shen WT, Duh QY, Clark OH, Kebebew E. Antineoplastic effects of decitabine, an inhibitor of DNA promoter methylation, in adrenocortical carcinoma cells. Arch Surg. 2010 Mar; 145(3):226-32.
  11. Shen WT, Ogawa L, Ruan D, Suh I, Kebebew E, Duh QY, Clark OH. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations. Arch Surg. 2010 Mar; 145(3):272-5.
  12. Shen WT. Parathyromatosis and parathyroid cancer. Cancer Treat Res. 2010; 153:105-16.
  13. Suh I, Filetti S, Vriens MR, Guerrero MA, Tumino S, Wong M, Shen WT, Kebebew E, Duh QY, Clark OH. Distinct loci on chromosome 1q21 and 6q22 predispose to familial nonmedullary thyroid cancer: a SNP array-based linkage analysis of 38 families. Surgery. 2009 Dec; 146(6):1073-80.
  14. Guerrero MA, Schreinemakers JM, Vriens MR, Suh I, Hwang J, Shen WT, Gosnell J, Clark OH, Duh QY. Clinical spectrum of pheochromocytoma. J Am Coll Surg. 2009 Dec; 209(6):727-32.
  15. Shen WT, Kebebew E, Suh I, Duh QY, Clark OH. Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy? Surgery. 2009 Aug; 146(2):296-9.
  16. Shen WT. A brief history of Orlo H. Clark. World J Surg. 2009 Mar; 33(3):369-71.
  17. Moalem J, Ruan DT, Farkas RL, Shen WT, Gosnell JE, Miller S, Duh QY, Clark OH, Kebebew E. Hemolysis falsely decreases intraoperative parathyroid hormone levels. Am J Surg. 2009 Feb; 197(2):222-6.
  18. Shen WT, Lee J, Kebebew E, Clark OH, Duh QY. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg. 2006 Aug; 141(8):771-4; discussion 774-6.
  19. Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg. 2006 Mar; 202(3):423-30.
  20. Shen WT, Wong TS, Chung WY, Wong MG, Kebebew E, Duh QY, Clark OH. Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells. Surgery. 2005 Dec; 138(6):979-84; discussion 984-5.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.